AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Rolandos Enterprises Public LTD

AGM Information Oct 31, 2016

2489_rns_2016-10-31_f1a166c7-047b-4d2b-9c4e-be728c29ef1d.pdf

AGM Information

Open in Viewer

Opens in native device viewer

Re: Decisions of the meeting of the Board of Directors of Rolandos Enterprises Public Ltd, dated 27.10.2016

The Group of companies of Rolandos Enterprises Public Ltd announces that, at its meeting of 27.10.2016, the Company's Board of Directors examined and approved matters concerning the investment and expansion plans of the Group's operations on the international market.

The Rolandos Enterprises Group has recently established a new company, named R Scientific Group Limited, a wholly owned subsidiary of Rolandos Enterprises Public Limited, responsible for the new scientific laboratories and the cosmetics production unit as well as the construction and operation of new microbiological and chemical laboratories. It is very important to note that, once established, the laboratories will be able to offer third parties the possibility to produce cosmetic products under a private label ("phantom brands"). This offers potential for turnover expansion in this new sector.

We would also like to inform you of the registration of the new Community Trade Mark under the name R GroupTM . R GroupTM will refer to the entire Group of companies of Rolandos and belongs exclusively to Rolandos Enterprises Public Limited. R GroupTM has been certified throughout the entire European Community as well as in the USA.

The second part of the announcement relates to our intention for complete restructuring of the cosmetics range, the image and manufacturing of Neoderma products. A large group of individuals and strategic associates has been working on this project since 2013. Also, we will very soon be able to reveal to the public the new, modern and dynamic trade name of NeodermaTM, which will reflect the renewed and restructured range of our products.

The Board of Directors estimates that the Group will be in a position to complete the above plans by the end of 2018. Investments in the period from 2016 to 2018 are expected to reach approximately €3 million.

The main objective is to expand the turnover as much as possible with a focus on the international market.

Yours sincerely

Rolandos Enterprises Public Limited Signed

Andreas Loizou CEO and Executive Member of the Board of Directors

Talk to a Data Expert

Have a question? We'll get back to you promptly.